MARATTO

review · Stroke Vascular and Interventional Neurology

Abstract 119: Lactate Dehydrogenase (LDH) as a Prognostic Biomarker in Patients with Ischemic Stroke: A Systematic Review and Meta‐Analysis

2024Open accessMinia University

Abstract

Ischemic stroke causes a significant worldwide health burden, with high morbidity and fatality rates. The absence of oxygen and glucose during an ischemia event triggers anaerobic metabolism, resulting in lactate accumulation and an increase in Lactate dehydrogenase (LDH) activity. Thus, in order to assess the LDH as a prognostic biomarker in IS, we conducted the first systematic review and meta‐analysis.

Research topics

  • Acute Ischemic Stroke Management
  • Neurological Disorders and Treatments
  • Stroke Rehabilitation and Recovery

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1161/svin.04.suppl_1.119

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.